Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2074921rdf:typepubmed:Citationlld:pubmed
pubmed-article:2074921lifeskim:mentionsumls-concept:C1565489lld:lifeskim
pubmed-article:2074921lifeskim:mentionsumls-concept:C0193388lld:lifeskim
pubmed-article:2074921lifeskim:mentionsumls-concept:C0268164lld:lifeskim
pubmed-article:2074921lifeskim:mentionsumls-concept:C0750484lld:lifeskim
pubmed-article:2074921lifeskim:mentionsumls-concept:C1548877lld:lifeskim
pubmed-article:2074921lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:2074921lifeskim:mentionsumls-concept:C0205088lld:lifeskim
pubmed-article:2074921lifeskim:mentionsumls-concept:C0132254lld:lifeskim
pubmed-article:2074921pubmed:issue4lld:pubmed
pubmed-article:2074921pubmed:dateCreated1991-4-17lld:pubmed
pubmed-article:2074921pubmed:abstractTextIt can be difficult to distinguish between primary hyperoxaluria at end-stage renal failure and secondary oxalosis, all the more as primary hyperoxaluria can be latent for a long time and occur at a late stage. A 57 year-old woman, without family nor personal history of urolithiasis, receives regular hemodialysis for a renal failure discovered at end-stage. Eighteen months later, calcium oxalate deposits appear in the skin, bone marrow and both kidneys, suggesting secondary oxalosis. An other 57 year-old woman presents a chronic renal failure due to bilateral urolithiasis, whose surgery has caused a dramatic decrease of renal function requiring regular hemodialysis. Because of apparition of severe bone alterations, a parathyroidectomy is realized, and because of calcium oxalate deposition in the skin and bone marrow, primary hyperoxaluria is suspected. In both observations, the enzyme activity determination in a liver biopsy gives the diagnosis of primary hyperoxaluria.lld:pubmed
pubmed-article:2074921pubmed:languagefrelld:pubmed
pubmed-article:2074921pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2074921pubmed:citationSubsetIMlld:pubmed
pubmed-article:2074921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2074921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2074921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2074921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2074921pubmed:statusMEDLINElld:pubmed
pubmed-article:2074921pubmed:issn0250-4960lld:pubmed
pubmed-article:2074921pubmed:authorpubmed-author:MahmoudMMlld:pubmed
pubmed-article:2074921pubmed:authorpubmed-author:CollinPPlld:pubmed
pubmed-article:2074921pubmed:authorpubmed-author:SchillingerFFlld:pubmed
pubmed-article:2074921pubmed:authorpubmed-author:MontagnacRRlld:pubmed
pubmed-article:2074921pubmed:authorpubmed-author:MilcentTTlld:pubmed
pubmed-article:2074921pubmed:issnTypePrintlld:pubmed
pubmed-article:2074921pubmed:volume11lld:pubmed
pubmed-article:2074921pubmed:ownerNLMlld:pubmed
pubmed-article:2074921pubmed:authorsCompleteYlld:pubmed
pubmed-article:2074921pubmed:pagination217-21lld:pubmed
pubmed-article:2074921pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:meshHeadingpubmed-meshheading:2074921-...lld:pubmed
pubmed-article:2074921pubmed:year1990lld:pubmed
pubmed-article:2074921pubmed:articleTitle[Adult type I primary hyperoxaluria: 2 cases confirmed by liver biopsy at end-stage renal insufficiency].lld:pubmed
pubmed-article:2074921pubmed:affiliationService de Néphrologie-Hémodialyse, CHG Troyes.lld:pubmed
pubmed-article:2074921pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2074921pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:2074921pubmed:publicationTypeCase Reportslld:pubmed